pyrrolidine dithiocarbamate has been researched along with Hypertrophy, Left Ventricular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cau, SB; Ceron, CS; Gerlach, RF; Guimaraes, DA; Rizzi, E; Tanus-Santos, JE | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension.
Topics: Animals; Blood Pressure; Collagen; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 2; NF-kappa B; Oxidative Stress; Pyrrolidines; Rats, Wistar; Thiocarbamates; Time Factors; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2015 |